(Q35585559)

9 August 2017

1 reference

title

Chemotherapy for urothelial tract malignancies: breaking the deadlock (English)

1 reference

9 August 2017

1 reference

Scher HI

1

1 reference

PubMed ID

1462103

9 August 2017

Norton L

series ordinal

2

1 reference

PubMed ID

1462103

9 August 2017

language of work or name

1 reference

1 September 1992

1 reference

Journal of Surgical Oncology

9 August 2017

1 reference

9 August 2017

8

1 reference

9 August 2017

316-341

1 reference

9 August 2017

5

1 reference

Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder

9 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

Radiotherapy with and without cisplatin in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

Adriamycin. A new anticancer drug with significant clinical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

Structure and expression of the human MDR (P-glycoprotein) gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSSU.2980080511

21 January 2018

Identifiers

DOI

10.1002/SSU.2980080511

1 reference

9 August 2017

1 reference

PubMed ID

1462103